Philogen announces its attendance at the TIDES 2022 (Oligonucleotide and Peptide Therapeutics) on May 9-12, 2022.

Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in solid lesions”.

See TIDES 2022 for more details.